Benzodiazepine behavioral side effects: Review and implications for individuals with mental retardation

American Journal on Mental Retardation

Volumn 107, Issue 5, 2002, Pages

  Kalachnik, John E ^a   Hanzel, Thomas E ^a   Sevenich, Robert ^a   Harder, Stuart R ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE; CHLORDIAZEPOXIDE; CLONAZEPAM; CLORAZEPATE DIPOTASSIUM; DIAZEPAM; ESTAZOLAM; FLURAZEPAM; HALAZEPAM; LORAZEPAM; OXAZEPAM; PRAZEPAM; QUAZEPAM; TEMAZEPAM; TRIAZOLAM;

ADULT; AGGRESSION; AGITATION; ANGER; ARTICLE; BEHAVIOR DISORDER; DISEASE EXACERBATION; FEMALE; HALLUCINATION; HUMAN; HYPERACTIVITY; HYPOMANIA; MAJOR CLINICAL STUDY; MALE; MENTAL DEFICIENCY; MYOCLONUS; PRESCRIPTION;

ADOLESCENT; ADULT; AGGRESSION; ANTI-ANXIETY AGENTS; BENZODIAZEPINES; CLINICAL TRIALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; HUMANS; MENTAL DISORDERS; MENTAL RETARDATION;

EID: 18544386114     PISSN: 08958017     EISSN: None     Source Type: Journal    
DOI: 10.1352/0895-8017(2002)107<0376:BBSERA>2.0.CO;2     Document Type: Article

References (154)

1. Brief report: Comparison effects of antecedent exercise and lorazepam on the aggressive behavior of an autistic man
2. Use of antiepileptic drugs in the treatment of epilepsy in people with intellectual disability
3. Psychotropic drugs in group homes: Prevalence and relation to demographic/psychiatric variables
4. Self-injury in Lesch-Nyhan disease
5. Pharmacological treatment of aggressive behavior and emesis in the Cornelia de Lange syndrome
6. Cold urticaria associated with intraoperative hypotention and facial edema
7. Guidelines for the rational use of benzodiazepines
8. Doubleblind, randomized trial of diazepam versus placebo for prevention of febrile seizures
9. Progressive dystonia in a child with chromosome 18p deletion, treated with intrathecal baclofen
10. Relationship of sedative-hypnotic response to self-injurious behavior and stereotypy by mentally retarded clients
11. Aggressive behavior in intellectually challenged patients with epilepsy treated with lamotrigine
12. Selective impairment in the recognition of anger induced by diazepam
13. Myoclonus in Down's syndrome. Association with Alzheimer's disease
14. Diagnosis and fluoxetine treatment of compulsive behavior disorder of adults with mental retardation
15. Differential effects of oxazepam and lorazepam on aggressive responding
16. Drug-induced behavioural dis-inhibition. Incidence, mechanisms, and therapeutic implications
17. Behavioural aggression in panic disorder after 8 weeks' treatment with alprazolam
18. Midazolam for aggressivity and violence in three mentally retarded patients
19. The 'happy puppet' syndrome
20. Sedation of the autistic patient for dental procedures
21. Selective serotonin re-uptake inhibitors for the treatment of perseverative and maladaptive behaviours of people with intellectual disability
22. Clonazepam
23. Chronic benzodiazepine dependence. A comparative study of abrupt withdrawal under propranolol cover versus gradual withdrawal
24. Residual catatonic state following neuroleptic malignant syndrome
25. Behavior modification of mentally retarded patients
26. Effects of triazolam on human aggressive, escape and point-maintained responding
27. Reduction of susceptibility to upper respiratory tract infections in Down's syndrome children following treatment with GABAergic drugs: Report of 70 cases
28. Case series: Catatonic syndrome in young people
29. Adverse behavioral events reported in patients taking alprazolam and other benzodiazepines
30. Behavioral disturbances in children treated with clonazepam
31. Fluoxetine treatment of children and adults with autistic disorder and mental retardation
32. Withdrawal of barbiturate anticonvulsant drugs: Prospective controlled study
33. Individuals with mental retardation in residential facilities: Findings from the 1987 National Medical Expenditure Survey
34. Comparison of the sedative effectiveness of two pharmacological regimens
35. Chloral hydrate-diazepam: Per os combination in treatment of disabled
36. Catatonic syndrome following recovery from neuroleptic malignant syndrome
37. Brief report: Catatonia in autistic disorders
38. Aggressive dyscontrol in patients treated with benzodiazepines
39. Advantages and disadvantages of benzodiazepines
40. Experiences with Rivotril™ in treatment of epilepsy particularly minor motor epilepsy in mentally retarded children
41. The effect of diazepam (Valium) in children with cerebral palsy: A double-blind study
42. Positive and negative psychotropic effects of lamotrigine in patients with epilepsy and mental retardation
43. Maladaptive behavior of institutionalized retardates with seizures
44. Experience with sedation and restraint during dental treatment in Romania
45. Benzodiazepines in the treatment of children with epilepsy
46. Effect of reduction of anticonvulsants on wellbeing
47. Schizophrenia-like psychosis associated with anti-convulsant toxicity
48. Clonazepam treatment of a mentally retarded woman
49. Dangerously aggressive behavior as a side effect of alprazolam
50. Adverse behavioral effects in individuals with mental retardation and mood disorders treated with carbamazepine
51. The sedative effect of intranasal midazolam administration in the dental treatment of patients with mental disabilities. Part 1 - The effect of a 0.2 mg/kg dose
52. Management of an autistic child undergoing open heart surgery
53. Lorazepam treatment of acute and chronic catatonia in two mentally retarded brothers
54. Long term clinical trial with diazepam on adult mentally retarded persons
55. Alprazolam-induced dyscontrol in borderline personality disorder
56. Disinhibition of behavior by antianxiety drugs
57. Effects of antiepileptic drugs and seizure type on operant responding in mentally retarded persons
58. Mania-like reaction induced by benzodiazepine withdrawal in a patient with mental retardation
59. Differential effects of diazepam and pentobarbital on mood and behavior
60. The treatment of epilepsy in autism
61. Inappropriate medication prescribing in homebound older adults
62. Paradoxical reaction to a new minor tranquilizer
63. Myoclonus in Down's syndrome: Treatment with clonazepam
64. Clonazepam in childhood anxiety disorders
65. Case study of neuroleptic-induced akathisia: Important implications for individuals with mental retardation
66. Paradoxical reactions to benzodiazepines. When to expect the unexpected
67. Paradoxical reactions to benzodiazepines
68. Results of barbiturate antiepileptic drug discontinuation on antipsychotic medication dose in individuals with intellectual disability
69. Use of aggression to signal and measure depressive episodes within a rapid cycling bipolar disorder in an individual with mental retardation
70. Significant anticonvulsant side-effects in children and adolescents
71. Behavioral problems and medication utilization
72. Sedation for the mentally handicapped patient
73. Factors relating to dramatic response to clobazam therapy in refractory epilepsy
74. Maladaptive behavior of mentally retarded individuals in residential facilities
75. Northern epilepsy syndrome: Clinical course and the effect of medication on seizures
76. The administration of psychotropic and anticonvulsant drugs to children with profound intellectual disability and multiple impairments
77. Problem behavior and psychiatric impairment within a developmentally disabled population I: Behavior frequency
78. Behavioral side effects of barbiturate antiepileptic drugs in individuals with mental retardation and developmental disabilities
79. Antiepileptic drug behavioral side effects in individuals with mental retardation and the use of behavioral measurement techniques
80. Guidelines for the use of psychopharmacologic medication
81. Comparison of short and long half-life benzodiazepine hypnotics: Triazolam and quazepam
82. Anxiety disorders in adults with mental retardation
83. Anaesthetic management of an adult with X-linked adrenoleukodystrophy
84. Neuroleptic-induced catatonia or a mild form of neuroleptic malignant syndrome?
85. A clinical study of chlordiazepoxide used in psychiatric disorders of children
86. Chlordiazepoxide in treatment of children with emotional disturbance
87. Limitations on the use of benzodiazepines in anxiety and insomnia: Are they justified?
88. The use of psychopharmacological agents in retarded children with behavior disorders
89. Implementation of an interdisciplinary psychotropic drug review process for community-based facilities
90. Clomipramine treatment for stereotypy and related repetitive movement disorders associated with mental retardation
91. Intravenous Sedation in dental treatment of the handicapped. A preliminary report of 25 severely handicapped patients
92. Midazolam disinhibition reaction
93. Assessment and treatment of mood disorders in persons with developmental disabilities
94. Severe behavior problems associated with rapid cycling bipolar disorder in two adults with profound mental retardation
95. Pharmacotherapy for severe aggression in a child with autism: "Open label" evaluation of multiple medications on response frequency and intensity of behavioral intervention
96. ECT for prolonged catatonia
97. Olanzapine-induced neuroleptic malignant syndrome with mental retardation
98. Paradoxical reactions elicited by diazepam in children with classic autism
99. Comparative study of the effects of captodiamine and lorazepam on car driving ability
100. Clobazam for refractory childhood seizure disorders - A valuable supplementary drug
101. Drop episodes in Coffin-Lowry syndrome: Exaggerated startle responses treated with clonazepam
102. Efficacy of lithium carbonate on public and compulsive masturbation: A female case with mild mental retardation
103. Benzodiazepine withdrawal: A review of the evidence
104. Safety and side-effects of alprazolam. Controlled study in agoraphobia with panic disorder
105. Randomized controlled trial to access acceptability of phenobarbital for childhood epilepsy in rural India
106. Psychotropic drugs used with adults and elderly adults who have mental retardation
107. Reflectivity and learning from aversive events: Toward a psychological mechanism for the syndromes of disinhibition
108. Effects of chlordiazepoxide in disturbed children: A pilot study
109. Comparative effects of librium and taractan on behavior disorders of mentally retarded children
110. Prescribing trends in psychotropic medications. Primary care, psychiatry, and other medical specialties
111. Clonazepam: A review of its pharmacological properties and therapeutic efficacy in epilepsy
112. Buspirone treatment of aggression and anxiety in mentally retarded patients: A multiple-baseline, placebo lead-in study
113. Agitation observed during treatment with newer hypnotic drugs
114. A double-blind, placebo controlled cross-over trial of carbamazepine in overactive, severely mentally retarded patients
115. Letter to the editor: Transient respiratory depression in two patients with Down's syndrome following midazolam premedication
116. Ketamine, midazolam and vecuronium infusion. Anesthesia for Down's syndrome and congenital heart disease
117. Clonazepam in the treatment of panic disorder with or without agoraphobia: A doseresponse study of efficacy, safety, and discontinuance
118. Expert consensus guideline series: Treatment of psychiatric and behavioral problems in mental retardation
119. Chlordiazepoxide-induced hostility in a small group setting
120. Two cases of premenstrual sleep terrors and injurious sleep-walking
121. The self-reporting of psychiatric medications in patients scheduled for elective surgery
122. Overview of psychotropic and nontraditional medication therapy in a mentally retarded/developmentally disabled population
123. Aggression in children treated with clobazam for epilepsy
124. Clobazam for intractable pediatric epilepsy
125. Antiepileptic drug status in adult outpatients with mental retardation
126. Anxiety disorders in the USA, 1990 to 1997. Trend in complaint, diagnosis, use of pharmacotherapy and diagnosis of comorbid depression
127. Fluoxetine treatment of depression and associated self-injury in two adults with mental retardation
128. Methodology of psychopharmacological studies with the retarded
129. Use of psychotropic medication in Oklahoma: A statewide survey
130. General anaesthesia of out-patients in paedodontics
131. High-potency benzodiazepines for the short-term management of panic disorder: The U.S. experience
132. Psychotropic medication treatment for destructive behavior based on neurobehavioral mechanisms of drug action
133. Tolerance during sedation in a pediatric ICU patient: Effects on the BIS monitor
134. Tranquillizers causing aggression
135. Oral midazolam for a mentally retarded patient
136. Pilot study with RO 5-4556 in emotionally disturbed retarded children
137. Disinhibitory reactions to benzodiazepines: A review
138. Benzodiazepine side effects: Role of pharmacokinetics and pharmacodynamics
139. Serum medazepam, diazepam, and n-desmethyldiazepam levels after single and multiple oral doses of medazepam
140. Effects of lorazepam on hyperactivity in retarded children
141. Effects of clorazepate, diazepam, and oxazepam on a laboratory measurement of aggression in men
142. Anxiolytics and sedatives
143. Anxiolytics in mental retardation
144. Disentangling disinhibition
145. Effects of diazepam (Valium) and trait anxiety on human physical aggression and emotional state
146. On-site seizure clinic. Impact on the welfare of mentally retarded, institutionalized patients
147. Sublingual lorazepam in childhood serial seizures
148. Oxazepam in psychoneuroses and "anxiety bound" psychosis